ESS vs FDMT · P/E 31, rev $1.89B vs rev $37.0K
Essex Property Trust Inc (ESS) versus 4D Molecular Therapeutics Inc (FDMT) — a side-by-side from cached financials, not a winner call.
Essex Property Trust Inc (ESS) is a reit - residential company listed on NYSE.
4D Molecular Therapeutics Inc (FDMT) is a biotechnology company listed on US.
Latest reported ESS revenue for 2025-12-31 was $1.89B. Net income was $702.8M. Revenue was up 6.4% from 2024-12-31 to 2025-12-31. ESS currently screens at market cap $18.91B and trailing P/E 30.9.
Latest reported FDMT revenue for 2024-12-31 was $37.0K. Net income was -$160.9M. Revenue was down 99.8% from 2023-12-31 to 2024-12-31. FDMT currently screens at market cap $518.1M.
ESS currently screens at market cap $18.91B and trailing P/E 30.9. FDMT currently screens at market cap $518.1M.
Not investment advice. Open the ESS and FDMT stock pages for the full models.
Not investment advice.